Sheel Biotech Limited H1 revenue rises 131%, PAT reaches Rs 3.39 crore
Key highlights
- SBL's H1 FY2027 revenue from operations was Rs 50.56 crore, up 131.39% year on year.
- SBL reported H1 FY2027 profit after tax of Rs 3.39 crore, compared with Rs 18.85 lakh a year earlier.
- SBL's total borrowings were Rs 19.79 crore at September 2026, versus Rs 8.98 crore at March 2026.
- SBL announced projects with combined value of Rs 35.92 crore, including a Rs 21.39 crore Jammu and Kashmir order.
powered by IRIS

Sheel Biotech Limited reported H1 FY2027 revenue from operations of Rs 50.56 crore, up 131.39% year on year, while profit after tax rose to Rs 3.39 crore from Rs 18.85 lakh. The half-year result was accompanied by borrowings of Rs 19.79 crore and trade receivables of Rs 66.29 crore at September 2026.
Know Sheel Biotech inside out
Results, valuation, peers and who's buying, in one view.
How much did SBL's H1 revenue increase?
SBL's revenue from operations increased 131.39% year on year to Rs 50.56 crore in H1 FY2027, from Rs 21.85 crore in H1 FY2026. Total income, including other income, rose 131.33% to Rs 50.88 crore from Rs 22.00 crore, while other income was Rs 32.59 lakh compared with Rs 14.63 lakh a year earlier.
The H1 revenue total was below the Rs 110.02 crore reported for full-year FY2026 because the presentation compares a half-year period with a full financial year. SBL identifies six divisions: tissue culture, greenhouse and packhouse, organic adoption and certification, planting and landscaping, farmer producer organisation formation and skill development, and berries. The presentation does not give revenue by division or identify which business generated the H1 increase.
Cost of material consumed rose faster than revenue, increasing 168.33% to Rs 33.29 crore from Rs 12.41 crore. Employee benefit expense increased 18.56% to Rs 8.20 crore, while other expenses rose 2.10% to Rs 3.50 crore. Total expenditure therefore increased 124.00% to Rs 44.98 crore from Rs 20.08 crore in H1 FY2026.
How did SBL's H1 profitability change?
SBL's profit after tax increased to Rs 3.39 crore in H1 FY2027 from Rs 18.85 lakh in H1 FY2026, a reported year-on-year increase of 1,695.97% from a low base. Profit before tax rose to Rs 4.13 crore from Rs 25.11 lakh, and total tax expense increased to Rs 74.09 lakh from Rs 6.26 lakh.
Earnings before interest, tax, depreciation and amortisation, or EBITDA, rose 208.31% to Rs 5.90 crore from Rs 1.91 crore. EBITDA margin widened to 11.67% from 8.76%, an increase of 2.91 percentage points. Revenue increased by Rs 28.71 crore, exceeding the Rs 24.90 crore increase in total expenditure, alongside the higher EBITDA recorded for the period.
Profit after tax margin rose to 6.70% in H1 FY2027 from 0.86% in H1 FY2026. Both H1 margins were below the full-year FY2026 figures in the presentation, which show EBITDA margin of 15.45% and profit after tax margin of 10.69%. Depreciation and amortisation declined 4.13% to Rs 49.18 lakh, while interest cost increased 11.37% to Rs 1.28 crore from Rs 1.15 crore.
Got a follow-up? Ask IRIS
What changed in SBL's borrowings and working capital?
SBL's total borrowings increased to Rs 19.79 crore at September 2026 from Rs 8.98 crore at March 2026. Short-term borrowings rose to Rs 14.51 crore from Rs 7.74 crore, while long-term borrowings increased to Rs 5.28 crore from Rs 1.24 crore. The two disclosed borrowing categories increased by Rs 10.81 crore over the six-month balance-sheet comparison.
Trade receivables rose to Rs 66.29 crore at September 2026 from Rs 61.81 crore at March 2026, an increase of Rs 4.48 crore. Inventories increased to Rs 31.68 crore from Rs 29.57 crore. Short-term loans and advances reached Rs 10.96 crore from Rs 2.96 crore, while other current assets increased to Rs 36.82 crore from Rs 31.31 crore.
Cash and cash equivalents moved in the opposite direction, falling to Rs 21.06 lakh at September 2026 from Rs 2.18 crore at March 2026. Current liabilities increased to Rs 33.45 crore from Rs 16.97 crore, including other current liabilities of Rs 15.35 crore against Rs 5.98 crore. Trade payables declined to Rs 2.54 crore from Rs 3.06 crore, meaning categories other than supplier payables accounted for the increase in current liabilities.
Total assets increased to Rs 169.79 crore at September 2026 from Rs 145.78 crore at March 2026. Non-current assets rose to Rs 23.84 crore from Rs 17.96 crore, as property, plant and equipment increased to Rs 14.05 crore from Rs 9.47 crore and capital work-in-progress reached Rs 5.42 crore from Rs 3.45 crore. Total equity increased to Rs 130.38 crore from Rs 126.99 crore, with reserves and surplus rising to Rs 110.02 crore while share capital remained Rs 20.35 crore.
Which announced projects could affect SBL's expansion plans?
SBL announced projects with a combined value of Rs 35.92 crore: a Rs 21.39 crore Jammu and Kashmir precision farming project and a Rs 14.53 crore blueberry growing infrastructure project. The company received a Letter of Allotment from Jammu & Kashmir Agro Industries Development Corporation Limited for the precision-farming project, which covers five Centres of Excellence across five districts and is to be executed on a turnkey basis.
The Rs 14.53 crore blueberry project covers infrastructure and growing systems for blueberry cultivation, and SBL says the commercial transaction has been finalised. Management identifies blueberries as a key focus area for future expansion and growth. The presentation does not state an execution timetable, expected revenue-recognition period, margin, payment terms or whether either announced project value was included in H1 FY2027 revenue.
SBL also says it secured institutional orders for blueberry projects in Jammu and Kashmir and Himachal Pradesh during H1 FY27. Its company overview cites 13 Centres of Excellence, operations in more than 15 states, tissue-culture laboratory production capacity of 1.5 crore, and 1,98,502 farmers empowered. These measures provide operating context for the agricultural infrastructure and horticulture activities described with the new orders.
Conclusion
SBL's H1 FY2027 figures show a substantial increase in scale and profitability: revenue increased by Rs 28.71 crore year on year, EBITDA rose to Rs 5.90 crore and profit after tax reached Rs 3.39 crore. The balance sheet also expanded by Rs 24.01 crore from March 2026, while receivables, inventories, advances and total borrowings increased and cash declined.
The next disclosed items to watch are execution of the Rs 21.39 crore Jammu and Kashmir turnkey project and progress on the Rs 14.53 crore blueberry infrastructure transaction. Management has identified berries as a future expansion focus, but the presentation leaves the timing of execution, revenue recognition, collections and project profitability unresolved.


